Disease Info Card

Graft-vs-host Disease

Information about Graft-vs-host Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Graft-vs-host Disease

Most recent studies have shown that Graft-vs-host Disease shares some biological mechanisms with acute-gvh-disease, acute-lymphocytic-leukemia, anemia, aplastic-anemia, autoimmune-diseases, autoimmune-reaction, chronic-graft-versus-host-disease, cytomegalovirus-infections, decreased-immunologic-activity-[pe], graft-vs-host-reaction, hematologic-neoplasms, infective-disorder, leukemia, leukemia-myelocytic-acute, lymphoma, malignant-neoplasms, myeloid-leukemia, myeloid-leukemia-chronic, neoplasms, pneumonia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Graft-vs-host Disease, and have been seen in publications frequently: Cell Activation, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Cytokine Production, Cytokine Secretion, Donor Selection, Hemopoiesis, Hypersensitivity, Immune Response, Localization, Lymphocyte Proliferation, Pathogenesis, Regeneration, Secretion, Sensitization, T Cell Activation, T Cell Proliferation, Tolerance Induction

Quite a number of genes have been found to play important roles in Graft-vs-host Disease, such as BCR, CD34, CD4, CD8A, CSF3, CTLA4, HLA-A, HLA-DQA1, HLA-DRB4, HLA-E, IFNG, IL10, IL2, IL2RA, IL4, MID1, NOD2, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.